Skip to main content
logo
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
10.03
-0.46 (-4.39%)
At close: May 22, 2026, 4:00 PM EDT
10.15
+0.12 (1.20%)
After-hours: May 22, 2026, 7:59 PM EDT

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $36.22M in the quarter ending March 31, 2026, with 77.54% growth. This brings the company's revenue in the last twelve months to $122.29M, up 201.29% year-over-year. In the year 2025, Zevra Therapeutics had annual revenue of $106.47M with 350.91% growth.

Revenue (ttm)
$122.29M
Revenue Growth
+201.29%
P/S Ratio
4.85
Revenue / Employee
$2,004,738
Employees
61
Market Cap
592.92M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025106.47M82.86M350.91%
Dec 31, 202423.61M-3.85M-14.02%
Dec 31, 202327.46M17.00M162.58%
Dec 31, 202210.46M-18.19M-63.50%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CorMedix400.05M
Gyre Therapeutics117.05M
Arvinas89.40M
Aclaris Therapeutics8.37M
Altimmune36.00K
Revenue Rankings

ZVRA News

More News